Hearing Loss in Mitochondrial Diseases
Author Information
Author(s): Nehzat Koohi, Sarah Holmes, Amanda Male, Doris-Eva Bamiou, Magdalena Dudziec, Gita Ramdharry, Chiara Pizzamiglio, Michael Hanna, Robert D S Pitceathly, Diego Kaski
Primary Institution: University College London
Hypothesis
A spectrum of auditory dysfunctions exists in patients with primary mitochondrial diseases, potentially exacerbating functional hearing impairment.
Conclusion
The study highlights the complex nature of hearing impairment in primary mitochondrial diseases, emphasizing the need for personalized auditory assessments and management strategies.
Supporting Evidence
- Participants with the m.3243A>G/T variants showed significant elevations in pure-tone audiometry thresholds, especially at high frequencies.
- The listening in spatialized noise-sentences test revealed significant spatial processing deficits in the m.3243A>G/T group.
- Auditory-evoked brainstem response results indicated a higher likelihood of abnormalities in the m.3243A>G/T group.
Takeaway
People with certain mitochondrial diseases can have trouble hearing because their ears and brain don't work together well. This study helps doctors understand how to help them better.
Methodology
An observational study involving extensive audiological evaluations and multivariate analysis of covariance and logistic regression analyses.
Limitations
The study's cohort may not fully represent the diversity of pathogenic mtDNA variants, and the lack of MRI findings limits insights into central auditory system structure.
Participant Demographics
Participants aged 20–81 years, with a mean age of 48.26 years, consisting of 49 females and 23 males.
Statistical Information
P-Value
<0.001
Confidence Interval
95% CI [0.001, 0.255]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website